Boothbay Fund Management, LLC Qiagen N.V. Transaction History

Boothbay Fund Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$39.13 - $47.24 $44,451 - $53,664	1,136 Added 13.97%	9,268 $375,000
Q2 2023 Aug 14, 2023	BUY	$43.93 - $46.76 $124,541 - $132,564	2,835 Added 53.52%	8,132 $366,000
Q1 2023 May 15, 2023	BUY	$45.29 - $50.76 $239,901 - $268,875	5,297 New	5,297 $243,000
Q2 2022 Aug 15, 2022	SELL	$42.98 - $49.77 $136,246 - $157,770	-3,170 Reduced 30.48%	7,229 $341,000
Q1 2022 May 16, 2022	BUY	$42.23 - $54.3 $439,149 - $564,665	10,399 New	10,399 $510,000

Q1 2020 May 15, 2020	SELL	$33.17 - $41.6 $232,521 - $291,616	-7,010 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$25.41 - $43.1 $178,124 - $302,131	7,010 New	7,010 $237,000
Q3 2018 Nov 14, 2018	SELL	$35.99 - $39.39 $287,920 - $315,120	-8,000 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$31.01 - $34.72 $3,101 - $3,472	-100 Reduced 1.23%	8,000 $258,000
Q4 2017 Feb 14, 2018	SELL	$30.68 - $35.37 $12,701 - $14,643	-414 Reduced 4.86%	8,100 $251,000
Q3 2017 Nov 14, 2017	BUY	$31.02 - $32.94 $264,104 - $280,451	8,514	8,514 $268,000

6.76M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $9.24B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.